Why Richmond Pharmacology - TQT under one roof

Thorough QT/QTc (TQT) studies are today an integral component in the development of new chemical entities (NCE) and on going drug development programmes. These studies are now so significant that they can mean the difference between the continuation and an abrupt halt of a drug development program.

When considering the conduct of a TQT study Richmond Pharmacology understands that ‘One Size Does Not Fit All’.

We place an emphasis on the fact that these studies need to be highly customised for each compound. A level of expertise way beyond the level of technical skill is essential in the planning and conduct of these studies. At Richmond Pharmacology we believe that there are three key elements to produce a successful TQT study. These are all important elements and at Richmond Pharmacology we place equal importance on

• Appropriate study design
• The quality of the ECG’s produced during clinical trial conduct
• The quality of the ECG analysis

Richmond Pharmacology believe the only way to fulfil these three key elemnts is to place these studies with research units able to provide both the conduct, analysis and interpretation of TQT studies.

At Richmond Pharmacology we are able to offer this combined competence. Our ability to provide sufficient data in a FDA compliant format with the inclusion of fewer volunteers coupled with the production of fewer ECG’s with a higher level of quality and less variability is key to our success internally and with our clients.